Fibrostenosis Focused Therapeutics
Crohn's and Colitis Foundation
The Crohn's & Colitis Foundation seeks to fund companies that are focused on developing products for the treatment of IBD patients experiencing fibrosis exclusive of surgical techniques resulting in removal of GI tissue. These products should have their origin in clinical observations and/or published evidence in human IBD.
Up to $450,000 USD for one year with additional $450,000 USD funding in subsequent periods contingent on exceptional progress towards specified milestones.
Deadlines
| UM Internal Deadline (to ADR) | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 31-May-2026 |
Application (Upon Invitation Only) | 24-Jul-2026 | 14-Aug-2026 |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.